Laura Gault
Chief Tech/Sci/R&D Officer at SAGE THERAPEUTICS, INC.
Net worth: 215 079 $ as of 2024-03-30
Profile
Laura Gault is currently the Chief Medical Officer at SAGE Therapeutics, Inc. Prior to her current position, she worked as the Vice President at Alexion Pharmaceuticals, Inc. from 2019 to 2022 and as the Vice President-Neurology Clinic Development at Vertex Pharmaceuticals, Inc. from 2017 to 2019.
Gault received her undergraduate degree from the University of Pittsburgh and her doctorate from Case Western Reserve University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0.02% | 2024-02-12 | 11,477 ( 0.02% ) | 215 079 $ | 2024-03-30 |
Laura Gault active positions
Companies | Position | Start |
---|---|---|
SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2022-10-30 |
Former positions of Laura Gault
Companies | Position | End |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-10-31 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2019-02-28 |
Training of Laura Gault
University of Pittsburgh | Undergraduate Degree |
Case Western Reserve University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SAGE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Laura Gault